Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.

Oudard, Stéphane; Latorzeff, Igor; Caty, Armelle; Miglianico, Laurent; Sevin, Emmanuel; Hardy-Bessard, Anne Claire; Delva, Remy; Rolland, Frédéric; Mouret, Loic; Priou, Franck; Beuzeboc, Philippe; Gravis, Gwenaelle; Linassier, Claude; Gomez, Philippe; Voog, Eric; Muracciole, Xavier; Abraham, Christine; Banu, Eugeniu; Ferrero, Jean-Marc; Ravaud, Alain; Krakowski, Ivan; Lagrange, Jean-Léon; Deplanque, Gaël; Zylberait, David; Bozec, Laurence; Houede, Nadine; Culine, Stéphane; Elaidi, Reza.
JAMA Oncol; 2019 Jan 31.
Artigo em Inglês | MEDLINE | ID: mdl-30703190

Não foram localizados documentos relacionados